您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC COMBINATIONS OF THEOBROMIN AND ANTIHISTAMINE
专利权人:
БАЙОКОУПИ ЛИМИТЕД (GB)
发明人:
БРЮ Джон (GB),БАННИСТЕР Робин Марк (GB)
申请号:
RU2012129675/15
公开号:
RU2012129675A
申请日:
2010.12.14
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. The drug (medication), including theobromine and antihistamine as a combined drug for simultaneous, sequential or separate use in therapy. 2. The agent of claim 1, wherein the therapy is a cough treatment. The agent according to claim 1, wherein the antihistamine is selected from diphenhydramine, loratadine, desloratadine, alimemazine, dimenhydrinate, doxylamine, meclizine, quetiapine, fexofenadine, pheniramine, cetirizine, promethazine, clemastine, chlorpheniramine, dexinazinazinofermene azinorisinofenamerin hydrochlorofin astemizole, fexofenadine, loratadine, cetirizine, levocetirizine, brompheniramine, dextrobrompheniramine, promethazine, misolastine and triprolidine. 4. The agent of claim 3, wherein the antihistamine is chlorpheniramine. 5. The agent according to any one of claims 1 to 4, wherein the dose of antihistamine for administration is from 0.1 to 30 mg / kg / day. A pharmaceutical composition comprising theobromine and an antihistamine. 7. A composition according to claim 6 wherein the antihistamine is selected from diphenhydramine, loratadine, desloratadine, alimemazine, dimenhydrinate, doxylamine, meclizine, Quetiapine, Fexofenadine, pheniramine, cetirizine, promethazine, clemastine, chlorpheniramine, dexchlorpheniramine, levocetirizine, hydroxyzine, alimemazine, acrivastine, cyproheptadine, astemizole, fexofenadine, loratadine, cetirizine, levocetirizine, brompheniramine, dextrobrompheniramine, promethazine, misolastine and triprolidine. 8. The composition of claim 7, wherein the antihistamine is chlorpheniramine. A composition according to any one of claims 6 to 8, wherein the dose of antihistamine for administration is from 0.1 to 30 mg / kg / day. The use of pharmaceutical com1. Средство (медикамент), включающее теобромин и антигистамин в качестве комбинированного препарата для одновременного, последовательного или раздельного применения в терапии.2. Средство по п.1, где терапия представляет собой лечение кашля.3. Средство по п.1, где антигиста
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充